XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.3

Accrued Expenses and Other Current Liabilities (Tables)

9 Months Ended

Sep. 30, 2024

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

		September 30,				December 31,
		2024				2023
		(in thousands)
Vaxcyte-related accrual under Vaxcyte Supply Agreement		$	9,440			$	6,933
CMO-related accrual			10,929				8,195
Clinical trials-related accrual			8,288				4,283
Tax and related expenses			18				15,165
Other			3,460				3,897
Total accrued expenses and other current liabilities		$	32,135			$	38,473

X

- Definition

Schedule of accrued liabilities and other liabilities disclosure, current.

+ References

No definition available.

+ Details

Name:	stro_ScheduleOfAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTableTextBlock
Namespace Prefix:	stro_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration